Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PEPPER trial
2022-502375-37-00Phase 4Completed
- Sponsor
- UZ Leuven
- Start
- Apr 2023
- Modality
- Small Molecules, Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, randomised trial of aluminum hydroxide + magnesium hydroxide and magnesium trisilicate in gastroesophageal reflux disease (GERD) and functional dyspepsia (FD) (3 arms), sponsored by UZ Leuven. Started Apr 2023; status: completed.
02
Drugs
aluminum hydroxide + magnesium hydroxidemagnesium trisilicate
03
Conditions
gastroesophageal reflux disease (GERD)functional dyspepsia (FD)
Beyond the preview
Go deeper on 2022-502375-37-00.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2022-502375-37-00.